FillPoint Health, a leading specialty pharmacy and MSO platform under Lyceum Health, is proud to announce an exclusive partnership with US Heart & Vascular (USHV), the nation’s premier cardiovas...

DUBLIN, Ohio: FillPoint Health, a leading specialty pharmacy and MSO platform under Lyceum Health, is proud to announce an exclusive partnership with US Heart & Vascular (USHV), the nation’s premier cardiovascular management services organization, to streamline access, dispensing, and patient support services for innovative RNA interference (RNAi) therapies for rare, inherited disorders in cardiovascular disease.
This collaboration marks a significant step in enhancing the care pathway for patients with complex cardiovascular and rare disease conditions by integrating clinical prescribing, specialty fulfillment, and real-time patient engagement through a unified provider-pharmacy model.
“This exclusive partnership aligns perfectly with our mission to bridge the gap between provider care and specialty therapy access,” said Michael Baldzicki, Chief Revenue Officer of Lyceum Health, A Group of Companies (RxNexus & FillPoint Health). “Together with US Heart & Vascular, we’re enabling earlier intervention, better adherence, and improved outcomes for a highly targeted patient population.”
Key Highlights of the Partnership:
“USHV is committed to delivering next-generation cardiovascular care,” said Emily Rash, Chief Operating Officer at USHV. “This partnership allows our physicians to focus on clinical care while ensuring their patients receive uninterrupted access to life-changing therapies. These advanced capabilities allow USHV partners to deliver the right therapy to the right patient at the right time.”
Through this collaboration, FillPoint Health leverages its specialty pharmacy infrastructure and digital capabilities to improve therapy access at the point of care-supporting physicians and patients with high-touch, precision-based services.
About FillPoint Health
FillPoint Health is a licensed and accredited specialty pharmacy and MSO platform under Lyceum Health, focused on enabling integrated care for complex and rare conditions. Through its national network, proprietary RxNexus platform, and Therapeutic Engagement Centers (TEC), FillPoint streamlines specialty prescribing, distribution, and outcomes-driven patient support. Visit FillPointHealth.com.
About US Heart & Vascular (USHV)
USHV is a leading national cardiovascular physician platform dedicated to supporting world-class care through clinical innovation, operational efficiency, and strategic partnerships across its growing network of practices. Visit USHeartandVascular.com.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
#bot--Arkose Labs, the leading fraud prevention, device ID and bot management company, has published "Enterprises Under Attack: Quarterly Threat Actor…
The "Validation of FDA-Regulated Systems Used in Drug Development & Submissions Using Artificial Intelligence (AI), Machine Learning (ML) & Large…
The 26th session of the UN Tourism General Assembly opened today in Riyadh, marking a historic first for the Gulf Cooperation Council (GCC) region and…
OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF 2nd Stage”),” covering from FY2026 to FY2030, on November…